INVO Bioscience, Inc. (INVO)
- Previous Close
1.0600 - Open
1.0500 - Bid 1.0200 x 100
- Ask 1.0400 x 100
- Day's Range
1.0200 - 1.0800 - 52 Week Range
0.5000 - 10.5000 - Volume
52,759 - Avg. Volume
3,892,153 - Market Cap (intraday)
2.806M - Beta (5Y Monthly) 1.49
- PE Ratio (TTM)
-- - EPS (TTM)
-5.1300 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
www.invobio.comRecent News: INVO
Performance Overview: INVO
Trailing total returns as of 4/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INVO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INVO
Valuation Measures
Market Cap
2.91M
Enterprise Value
17.36M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.55
Price/Book (mrq)
--
Enterprise Value/Revenue
5.75
Enterprise Value/EBITDA
-2.52
Financial Highlights
Profitability and Income Statement
Profit Margin
-266.00%
Return on Assets (ttm)
-33.85%
Return on Equity (ttm)
--
Revenue (ttm)
3.02M
Net Income Avi to Common (ttm)
-8.03M
Diluted EPS (ttm)
-5.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
232.42k
Total Debt/Equity (mrq)
972.59%
Levered Free Cash Flow (ttm)
641.46k
Research Analysis: INVO
Company Insights: INVO
INVO does not have Company Insights